Form4.ai tracks every SEC insider trade in real time. See every DCOY insider filing with a free account — no card.
See every DCOY insider filing — free account, no card.
Free accountDecoy Therapeutics Inc. (DCOY) has 10 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Sept. 2, 2026.
Open-market value, last 90 days
No open-market buys or sales in this period.
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Sep 2, 2026 SEC filing | Lieber Jonathan I Director | Grant / award | — | — |
| Sep 2, 2026 SEC filing | PIERCE FREDERICK II Chief Executive Officer | Grant / award | — | — |
| Sep 2, 2026 SEC filing | Marschel Peter Klaus Chief Business Officer | Grant / award | — | — |
Create a free account to see all 10 DCOY filings from the last 90 days. No card needed.
Create free accountWant DCOY insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.